Page results
-
Occupational therapists support people to do activities which are important to them, but which may be difficult because of health conditions.
-
Digital accessibility and sustainability drive a switch to online patient information at UCLH
-
The rhinology unit covers all aspects of nose and sinus disease including allergy, infection, inflammatory/mucosal conditions, breathing disorders and tumours.
-
Online form for beginning the sefl referral process at UCLH maternity services.
-
The Dermatology Department at University College Hospital is located in the Mortimer Market Centre and is housed in a newly refurbished dedicated skin clinic area where we see all of our adult patients for their outpatient appointments as well as surgical procedures and phototherapy.
-
The FGM service provides consultations, assessments, and support and referral to other services where clinically indicated
-
Treatment and rehabilitation of adolescents and children with complex conditions service (TRACCS) at UCLH. Formerly the Children and young people's chronic fatigue syndrome service.
-
Radiotherapy Department Patient Information series no. 18 - prostate brachytherapy prostate high dose rate (HDR) brachytherapy
-
This information is for patients who are receiving radiotherapy to the prostate or prostate bed. It explains what the treatment involves, describes side-effects you may experience during and after treatment, and how best to cope with them.
-
Information about Cerebral AVM (Arterio Venous Malformation) Endovascular Treatment at the NHNN
File results
-
FOI/2024/0506 - Permanent/ fixed-term/ international recruitment
-
FOI/2024/0509 - Structure chart for Estates and Facilities
-
FOI/2024/0511 - Radiotherapy treatment planning system/artificial intelligence (AI)/ costs
-
FOI/2024/0512 - Patient harm and the cost 2020-2023
-
FOI/2024/0513 - Robotic platforms for surgery costs/ contract
-
FOI/2024/0514 - Viscosupplementation injections/ spend
-
FOI/2024/0518 - Post partum balloons buying/ usage numbers
-
FOI/2024/0520 - Treatment of melanoma
-
FOI/2024/05523 - Dabrafenib + Trametinib cancer treatment for metastatic and adjuvant melanoma/ lung/ colorectal cancer
-
FOI/2024/0527 - Treatment for renal cell carcinoma